ConductScience.org, home

Gene · 55

ACP3: acid phosphatase 3

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. ACP3: acid phosphatase 3. Genes, record 55. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/55

On this page

Gene

Symbol
ACP3
HGNC
Name
acid phosphatase 3
HGNC
NCBI Gene ID
55
NCBI Gene
HGNC ID
HGNC:125
HGNC
Ensembl
ENSG00000014257
NCBI Gene
Aliases
5'-NT, ACP-3, ACPP, PAP, TM-PAP
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P15309Prostatic acid phosphatase38617Ensembl, GeneID, HGNC

Source UniProt

Patents117

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1436035P15309Espacenet
EP 4641201 A22025-10-296047P15309Espacenet
JP 2025147176 A2025-10-06165P15309Espacenet
JP 2025529142 A2025-09-04237P15309Espacenet
JP 2025529142 A2025-09-045357P15309Espacenet
US 12371689 B22025-07-29237P15309Espacenet
US 12371689 B22025-07-295357P15309Espacenet
JP 2025517969 A2025-06-126047P15309Espacenet
JP 2025062604 A2025-04-141345P15309Espacenet
US 12252547 B22025-03-1821P15309Espacenet

1 to 10 of 117

See all 117 patents

Drugs1

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismAction
SIPULEUCEL-TCHEMBL1237024Prostatic acid phosphatase binding agentBINDING AGENT

Source ChEMBL

Trials34

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT07219147SIPULEUCEL-TPHASE1ClinicalTrials.gov
NCT06134232SIPULEUCEL-TPHASE2ClinicalTrials.gov
NCT06100705SIPULEUCEL-TPHASE2ClinicalTrials.gov
NCT05806814SIPULEUCEL-TPHASE1ClinicalTrials.gov
NCT03686683SIPULEUCEL-TPHASE32024-10-08ClinicalTrials.gov
NCT03024216SIPULEUCEL-TPHASE1ClinicalTrials.gov
NCT02793765SIPULEUCEL-TPHASE2ClinicalTrials.gov
NCT02793219SIPULEUCEL-TPHASE2ClinicalTrials.gov
NCT02463799SIPULEUCEL-TPHASE22021-07-08ClinicalTrials.gov
NCT02353715SIPULEUCEL-TClinicalTrials.gov

1 to 10 of 34

See all 34 trials

NIH grants1,290

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleACP3 papersNewest fiscal year
ZIABC010666Cancer Immunotherapy302025
P30CA016672Cancer Center Support Grant282025
P30CA006973Regional Oncology Research Center242025
P30CA014520UW Comprehensive Cancer Center Support232025
P30CA008748Cancer Center Support Grant182025
P50CA097186The Pacific Northwest Prostate Cancer SPORE122025
ZIABC010598Human Immune Responses to Tumor Antigens for Cancer Immunotherapy82025
P30CA086862Cancer Center Support Grant72025
P50CA092629SPORE in Prostate Cancer72025
P30CA016042Cancer Center Support Grant62025

1 to 10 of 1,290Source NIH's project files

See all 1,290 nih grants

Papers3,704

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Vaccines for Cancer: A Translational Science Review.JAMA202642766303PubTator, text miningPubMed
Tobramycin-Peptide Nucleic Acids Synergize with Polymyxin B and Other Bioactive Compounds to Inhibit Growth of Gram-Negative Bacteria.ACS Infect Dis202642725966PubTator, text miningPubMed
Epidermotropic Metastatic Prostate Adenocarcinoma With Florid Squamous Transformation/Differentiation and Associated Acantholysis. An Unusual Clinicopathologic Entity.Case Rep Dermatol Med202642699160PubTator, text miningPubMed
Eradication of pre-clinical prostate tumors by a lentiviral vector-based immunotherapy.Mol Ther Oncol202642598525PubTator, text miningPubMed
Prostate Cancer Recurrence Mimicking a Primary Paranasal Sinus Tumor on 18F-FDG PET/CT During Treatment for Metastases After 10 Years of Remission.Case Rep Radiol202642569055PubTator, text miningPubMed
Prostatic Acid Phosphatase (PAP) Antibodies to Treat Castration-Resistant Prostate Cancer.Int J Mol Sci202642511478PubTator, text miningPubMed
ACP3-targeted PET imaging agents based on small-molecule ligands for prostate cancer diagnostics and theranostics.Am J Nucl Med Mol Imaging202642495193PubTator, text miningPubMed
Transcriptome analysis of follicular granulosa cells in young women with diminished ovarian reserve.Reprod Biol Endocrinol202642458461PubTator, text miningPubMed
Prostate Cancer: Etiology, Diagnosis, and Treatment.Serican J Med202642375929PubTator, text miningPubMed
Atypical Presentation of Metastatic Prostate Adenocarcinoma in the Presacral Space: A Case Report of Diagnostic Resection via the Kraske Approach.Am Surg202642360889PubTator, text miningPubMed

1 to 10 of 3,704

See all 3,704 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/55

GET https://conductscience.org/api/genes/v1/55/patents?page=2